HIVClinicalForum
Meeting category
Date(s)
8 Jun 2018
Location
Beijing, China
Organizer

Chinese HIV Clinical Forum 2018

Related Enduring Materials

Enduring Materials
Session 1: Introduction to Integrase Inhibitors -
HIV integrase Inhibitors: A novel mechanisms of action
placeholder3
Dr. H. Wu
Beijing You’an Hospital, Beijing, China
Resistance Characteristics of different Integrase Inhibitors
Charles Boucher, MD, PhD
Erasmus Medical Center, The Netherlands
The role of Integrase Inhibitors in International Treatment Guidelines
Mark Boyd, BA, BM, BS, DCTH&H, MHID, MD, FRACP
University of Adelaide, Australia
Charles Boucher, MD, PhD
Erasmus Medical Center, The Netherlands
Abstract-driven presentation: Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Treatment-Naïve Asian Adults: Week 144 results
placeholder3
Tina Zheng
Gilead, China
Session 2: Optimal Use of Integrase Inhibitors in the Clinic -
Optimal use of integrase inhibitors in routine clinical practice
Taiwan’s Experiences with Integrase Inhibitors
Chien-Ching Hung, MD, PhD
National Taiwan University Hospital & National Taiwan University Hospital Yunlin Branch / National Taiwan University College of Medicine, Taiwan
Abstract-driven presentation: Efficacy and Safety of Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir alafenamide (E/C/F/TAF) in Virologically Suppressed Asian Adults with Renal Impairment: 144 Week
placeholder3
Ning Li
Gilead, China
Session 3: The use of Integrase Inhibitors in Special Populations -
HIV - Hepatitis Co-infected patient (not available)
Weiping Cai, MD, PhD
Guangzhou Medical University, China
Long-term HIV treatment: The Importance of Initial Antiretroviral Regimen Selection
Hongxin Zhao, MD, MPH
Beijing Ditan Hospital, Capital Medical University, China
Overview
Welcome

We would like to thank you for joining us at the Chinese HIV Clinical Forum 2018 in Beijing, China! With excellent discussions and lectures during this meeting! We hope you enjoyed it too.

We would like to thank Gilead for providing the unrestricted educational grant that made this meeting possible.

Background

The HIV CLINICAL FORUM is developed as part of a series of interactive programs that provide independent medical education on emerging topics in HIV. The program features International and regions experts in order to provide HIV clinicians and allied healthcare professionals with updates on the latest developments related to HIV management, providing opportunities for sharing of clinical experience and presenting results from ongoing and completed cohorts/research programs.

Support
Language